Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) was upgraded by analysts at LADENBURG THALM/SH SH from a “neutral” rating to a “buy” rating in a report released on Tuesday, Briefing.com reports. The firm currently has a $8.00 target price on the stock. LADENBURG THALM/SH SH’s target price would suggest a potential upside of 143.16% […]
Evaxion Biotech (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to…
Evaxion Announces Business Update and Full Year 2023 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reiterated their buy rating on shares of Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $14.00 price objective on the stock. Separately, LADENBURG THALM/SH SH reiterated a neutral rating on shares of Evaxion Biotech A/S in a research note on Thursday, […]